Eagle Asset Management’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-33,132
| Closed | -$15.5M | – | 549 |
|
|
2023
Q1 | $15.5M | Sell |
33,132
-2,993
| -8% | -$1.4M | 0.09% | 192 |
|
|
2022
Q4 | $14.4M | Buy |
36,125
+6,580
| +22% | +$2.62M | 0.09% | 197 |
|
|
2022
Q3 | $9.61M | Buy |
+29,545
| New | +$9.61M | 0.06% | 245 |
|
|
2019
Q2 | – | Sell |
-37,888
| Closed | -$51.5M | – | 648 |
|
|
2019
Q1 | $51.5M | Buy |
37,888
+101
| +0.3% | +$137K | 0.27% | 145 |
|
|
2018
Q4 | $43.7M | Sell |
37,787
-687
| -2% | -$795K | 0.28% | 149 |
|
|
2018
Q3 | $58.4M | Sell |
38,474
-394
| -1% | -$598K | 0.28% | 146 |
|
|
2018
Q2 | $60.8M | Buy |
38,868
+6,063
| +18% | +$9.49M | 0.33% | 115 |
|
|
2018
Q1 | $37.9M | Buy |
32,805
+50
| +0.2% | +$57.7K | 0.21% | 174 |
|
|
2017
Q4 | $39M | Sell |
32,755
-423
| -1% | -$504K | 0.21% | 168 |
|
|
2017
Q3 | $46.2M | Buy |
+33,178
| New | +$46.2M | 0.26% | 136 |
|